Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Reddy's Laboratories has filed copies of newspaper advertisements published on July 24, 2025 in Financial Express and Andhra Prabha, containing the company's unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. The Board of Directors had approved these results at their meeting held on July 23, 2025, based on the recommendations of the Audit Committee. The filing was made to NSE, BSE, NYSE and NSE IFSC in compliance with Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The detailed results and related press release are also available on the company's website for investors. The document is signed by K Randhir Singh, Company Secretary and Compliance Officer.
This is a routine regulatory compliance filing and does not by itself move the stock. However, it serves as a formal public dissemination of the Q1 FY26 results that the Board approved a day earlier, making the numbers broadly accessible to retail shareholders and general public through newspaper circulation.